Latest news

Daily Snap - 11. August 2025

Daily Snap - 11. August 2025

Joachim Eeckhout
Gilead axes 3 drug programs, including Novo-partnered MASH treatment

Gilead axes 3 drug programs, including Novo-partnered MASH treatment

Joachim Eeckhout
BioNTech settles $870M patent dispute with CureVac, clearing path for $1.25B buyout

BioNTech settles $870M patent dispute with CureVac, clearing path for $1.25B buyout

Joachim Eeckhout
Daily Snap - 8. August 2025

Daily Snap - 8. August 2025

Joachim Eeckhout
XtalPi and DoveTree launch $6B AI-powered push to “drug the undruggable”

XtalPi and DoveTree launch $6B AI-powered push to “drug the undruggable”

Joachim Eeckhout
Strand Therapeutics lands $153M to push forward “programmable” mRNA cancer drugs

Strand Therapeutics lands $153M to push forward “programmable” mRNA cancer drugs

Joachim Eeckhout
OpenAI-backed Chai raises $70M to fast-track AI-driven drug discovery

OpenAI-backed Chai raises $70M to fast-track AI-driven drug discovery

Joachim Eeckhout
Nxera doubles down on obesity drugs as Pfizer, Novo and Terns exit GLP-1 candidates

Nxera doubles down on obesity drugs as Pfizer, Novo and Terns exit GLP-1 candidates

Joachim Eeckhout
Daily Snap - 6. August 2025

Daily Snap - 6. August 2025

Joachim Eeckhout
SERB buys Y-mAbs for $412M to expand rare cancer pipeline

SERB buys Y-mAbs for $412M to expand rare cancer pipeline

Joachim Eeckhout
HHS halts $500M in mRNA vaccine projects under Kennedy’s directive

HHS halts $500M in mRNA vaccine projects under Kennedy’s directive

Joachim Eeckhout
Daily Snap - 5. August 2025

Daily Snap - 5. August 2025

Joachim Eeckhout
FirstBack
1234567
Next Last